| Literature DB >> 31692655 |
Perditer Okyere1, Isaac Okyere2, Thomas Akuetteh Ndanu3, Charlotte Osafo3, Bright Amankwaa1.
Abstract
INTRODUCTION: Acute kidney injury (AKI) is a challenging problem in developing countries due to late presentation of its victims to health care facilities. Data on the pattern of AKI, its outcome and factors associated with its recovery is scanty in developing countries therefore impeding AKI management. Aim: to study AKI recovery rate and its associated factors.Entities:
Keywords: AKI; associated factors; recovery rate
Mesh:
Substances:
Year: 2019 PMID: 31692655 PMCID: PMC6814901 DOI: 10.11604/pamj.2019.33.236.15507
Source DB: PubMed Journal: Pan Afr Med J
Socio-demographic, haematologic and biochemical characteristics of study participants
| Variables | Frequency | Percentage |
|---|---|---|
| n = 191 | (%) | |
| 41.9 ± 19.2 | ||
| ≤ 29 | 66 | 34.6 |
| 30 - 39 | 44 | 23 |
| 40 - 60 | 45 | 23.6 |
| >60 | 36 | 18.8 |
| Male | 84 | 44 |
| 130.7 ± 23.3 | ||
| Normal | 54 | 30.4 |
| pre-hypertension | 86 | 45 |
| stage 1 | 32 | 16.8 |
| stage 2 | 15 | 7.9 |
| 80.0 ± 16.9 | ||
| Normal | 95 | 49.7 |
| pre-hypertension | 51 | 26.7 |
| stage 1 | 27 | 14.1 |
| stage 2 | 18 | 9.4 |
| 9.3 ± 2.9 | ||
| Anaemia | 44 | 23 |
| 13.7(9.1 - 19.7) | ||
| leukocytopenia | 7 | 3.7 |
| leukocytosis | 127 | 66.5 |
| 243.0(134.5 - 325.0) | ||
| thrombocytopenia | 29 | 15.2 |
| thrombocytosis | 24 | 12.6 |
| 124.7 ± 38.1 | ||
| hyponatremia | 92 | 48.4 |
| Hypernatremia | 14 | 74 |
| 4.5 ± 1.8 | ||
| Hypokalaemia | 33 | 17.3 |
| Hyperkalaemia | 51 | 26.7 |
SD: standard deviation
Figure 1Consort diagram explaining the AKI methodology and kidney function outcome
Clinical presentation of study participants
| Variables | Frequency | Percentage (%) |
|---|---|---|
| Fever | 87 | 45.5 |
| Diarrhoea | 45 | 16.8 |
| Rash | 32 | 16.8 |
| Peripheral oedema | 62 | 32.5 |
| Pulmonary oedema | 43 | 22.5 |
predictors of recovery from acute kidney injury at Korle-bu Teaching Hospital
| Variable | Not Recovered, N = 157(82.2%) | Recovered N = 34(17.8%) | OR(95%CI) | P – value |
|---|---|---|---|---|
| ≤ 29 | 9(26.5) | 57(36.3) | 1 | |
| 30 - 39 | 5(14.7) | 39(24.8) | 1.2(0.4 - 4.0) | 0.726 |
| 40 - 60 | 12(35.3) | 33(21.0) | 0.4(0.2 - 1.1) | 0.090 |
| >60 | 8(23.5) | 28(17.8) | 0.6(0.2 - 1.6) | 0.270 |
| Male | 17(50.0) | 67(42.7) | 1 | |
| female | 17(50.0) | 90(57.3) | 1.3(0.6 - 2.8) | 0.436 |
| Stage I | 2(5.9) | 19(14.1) | 1 | |
| Stage II | 4(11.8) | 9(6.7) | 1.6(0.3 – 14.2) | 0.544 |
| Stage III | 28(82.4) | 107(79.3) | 0.4(0.2 – 0.8) | |
| normal | 9(26.4) | 49(31.2) | 1 | |
| pre-hypertension | 13(38.5) | 73(46.5) | 1.0(0.4 - 2.6) | 0.948 |
| stage 1 | 8(23.5) | 24(15.3) | 0.6(0.2 - 1.6) | 0.275 |
| stage 2 | 4(11.8) | 11(7.0) | 0.5(0.1 - 1.9) | 0.320 |
| normal | 17(50.0) | 78(49.7) | 1 | |
| pre-hypertension | 4(11.8) | 47(29.9) | 2.6(0.8 - 8.1) | 0.108 |
| stage 1 | 7(20.8) | 20(12.7) | 0.6(0.2 - 1.7) | 0.357 |
| stage 2 | 6(17.6) | 12(7.6) | 0.4(0.1 - 1.3) | 0.143 |
| anaemia | 8(23.5) | 36(22.9) | 1 | |
| non-anaemia | 26(76.5) | 121(77.1) | 1.0(0.4 - 2.5) | 0.940 |
| leukocytopenia | 2(5.9) | 5(3.2) | 1 | |
| normal | 10(29.4) | 47(29.9) | 1.9(0.3 - 11.1) | 0.486 |
| leukocytosis | 22(64.7) | 105(66.9) | 1.9(0.3 - 10.5) | 0.457 |
| thrombocytopenia | 5(14.7) | 24(15.3) | 1 | |
| normal | 26(76.5) | 112(71.3) | 0.9(0.3 - 2.6) | 0.84 |
| thrombocytosis | 3(8.8) | 21(13.4) | 1.5(0.3 - 6.8) | 0.633 |
| hyponatremia | 22(64.7) | 70(44.6) | 1 | |
| normal | 10(29.4) | 74(47.1) | 2.3(1.1 - 5.3) | |
| hypernatremia | 2(5.9) | 12(7.6) | 1.9(0.4 - 9.1) | 0.429 |
| hypokalaemia | 6(17.6) | 27(17.2) | 1 | |
| normal | 20(58.8) | 87(55.4) | 1.0(0.4 - 2.7) | 0.948 |
| hypernatremia | 8(23.5) | 43(27.4) | 1.2(0.4 - 3.8) | 0.765 |
Data is represented at frequency, n(%), OR = Odds Ratio, CI = confidence interval, WBC = white blood cells
Figure 2Stages of AKI among the study participants